Aided by strong demand recovery, credit ratio rebounds to 1.33 in H2FY21, from 0.54 in H1FY21. GDP could grow at 11% in FY22, but the resurgence in Covid-19 cases is a key downside risk, says CRISIL.
Leading economists believe the vaccine might not end the economic disruption which the Covid-19 pandemic has caused. Normalcy will come over time, and with pain.
Minister says more output and effective implementation were key; Aatma Nirbhar Bharat not about closing doors to the world but of greater global engagement from a position of strength.
